UK BioTech Thalia Therapeutics Raises €3.1 Million and Acquires Sanmirna Therapeutics to Advance RNA Cancer Treatments
British biotechnology company Thalia Therapeutics has announced a significant milestone in its growth journey after securing €3.1 million (£2.75 million)…
